Skip to main content

Table 2 Hazard ratios (P wave ≥114 ms vs. P wave <114 ms) for total mortality, CVD and stroke mortality stratified by prevalent non-major macrovascular disease (PNMMVD)

From: Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease

 

HR (95% CI)

 

Age-adjusted hazard ratios

Multivariate-adjusted hazard ratios

Variables

P wave ≥114 vs. <114 ms

P for interaction

P wave ≥114 vs. <114 ms

P for interaction

Total mortality

    

No PNMMVD

0.75 (0.50-1.13)

 

0.70 (0.45-1.09)

 
  

0.020

 

0.047

PNMMVD

1.31 (1.03-1.66)*

 

1.18 (0.90-1.54)

 

CVD mortality

    

No PNMMVD

0.63 (0.36-1.10)

 

0.22 (0.27-0.90)*

 
  

0.010

 

0.015

PNMMVD

1.45 (1.09-1.93)*

 

1.32 (0.95-1.84)

 

Stroke mortality

    

No PNMMVD

0.47 (0.11-2.04)

 

0.36 (0.08-1.66)

 
  

0.057

 

0.089

PNMMVD

2.25 (1.18-4.31)*

 

2.45 (1.11-5.37)*

 
  1. *P < 0.05 for the difference between P wave ≥114 vs. <114 ms. Variables in multivariate adjusted: age, sex, area of residence, diabetes duration, total cholesterol, HDL cholesterol, triglycerides(log), proteinuria(log), smoking, alcohol, HbA1, presence of hypertension, BMI, type of diabetes therapy, physical activity, heart rate and left ventricular hypertrophy.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us